Patient: Page 19
-
PharmaVoice Team/PharmaVoice
mHealth
Remote Patient Monitoring Device Market to Reach $1.5 Billion by 2024 Trending Now: From smart bras to inhalers, remote monitoring devices continue to gain traction. Cardiovascular Diseases, Respiratory Disorders, and Diabetes Drive Growth in Global Remote Patient Monitoring Device Market Accord...
By PharmaVoice Team • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Trending 2017: Gene Editing
The development of human therapeutics using gene editing technologies is an area of major interest that has recently received large public and private investments. The initial applications of gene editing technologies have largely focused on the treatment of monogenic disorders, but other areas, ...
By PharmaVoice Team • Nov. 21, 2016 -
Explore the Trendline➔
Stock via Getty Images
TrendlineCommercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Trending 2017: Health Bots
Over the past several years, technological innovations in the healthcare industry have come and gone, but only a handful of trends have matured and achieved widespread adoption among healthcare organizations, according to experts at TechTarget, who add that bots are another new development that i...
By PharmaVoice Team • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Trending 2017: Precision Medicine
Precision medicine holds great promise for improving patient health outcomes. By identifying genetic causes of diseases, doctors can focus on disease prevention, earlier diagnosis when treatments may be more effective, and avoid giving treatments to patients that may cause adverse reactions or th...
By PharmaVoice Team • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
The Evolution of Patient Communities
Patient and community outreach have changed over the last decade. Patient organizations and pharmaceutical companies have been building communities, especially online communities of patients, because they recognize the opportunity to provide support and information exchange. Social media has had ...
By Denise Myshko • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
French Connection: Picture of an Evolving Market
France is the second-largest European market and one of the world’s largest consumers of pharmaceutical products. The French pharmaceutical industry grew by 17.9% between 2000 and 2010, compared with growth of 6.1% in the manufacturing sector. This performance can be explained by solid scientific...
By Kim Ribbink • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Patient Solutions: Patients Are No Longer Patient for Solutions
Over the past few years, the term patient-centric has been used so frequently that it almost has no meaning. But despite the centricity over the concept, the strategy of putting patients squarely in the middle of what the industry is doing and where it needs to go is sound. In parallel, the conce...
By Taren Grom • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Helping Patients Help Themselves
One of the biggest challenges in healthcare begins the moment a patient steps out of the doctor’s office or clinic. Suddenly, that individual assumes the bulk of responsibility for managing his or her condition on a daily basis — day after day, good mood or bad, on vacations, at work and at home....
By Jennifer Sigaud • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Creating a More Efficient, Effective, and Easier Model for Patient Care
It’s a challenge that continues to keep many pharmaceutical leaders up at night: how to advance patient-oriented programs in an industry addicted to the use of middlemen. A myriad of players, including PBMs (pharmacy benefit managers), wholesalers, specialty pharmacies, and other “hub" service co...
By Marie Lamont • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Addressing Whole Patient Needs: A New Model for Pharma
In today’s healthcare environment, there is more pressure to deliver optimal patient outcomes with greater efficiency. Traditional marketing approaches that rely on messaging to promote patient acceptance of therapy and adherence are not enough to drive real-world impact. To stay relevant, the ph...
By Jessica Brueggeman • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Not "Patients," But People
Finding Inspiration on Customer-Centric Marketing From Other Walks of Life Let’s not be healthcare marketers for a moment. Let’s be us: men, women, parents, grandparents, grandchildren, children, aunts, uncles, even pet parents. Sometimes we get sick. Our loved ones may suffer a heart attack. Alz...
By Johanna Skilling • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Personal Patient Connections Generate Real-world Results
In today’s plugged in, non-stop digital world, pharma brands are finding that helping patients create a personal, ongoing connection with a healthcare professional is a core catalyst for adherence to therapy, a more satisfying patient journey, brand loyalty, and — ultimately — improved patient ou...
By Abigail Mallon • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
mHealth
Battery-less, Stretchable Patch Provides More Options for Health Monitoring Trending now: Innovative solutions lead to next generation mHealth tools. John Rogers, Ph.D., founder of MC10 and a materials scientist at the University of Illinois at Urbana-Champaign, has introduced a wearable electro...
By PharmaVoice Team • Sept. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Calendar
August 8-9 3rd Life Science Knowledge Management Summit Sonesta Hotel Philadelphia, Philadelphia ExL Events, http://exlevents.com/3rd-life-science-knowledge-management-summit/ August 9-11 4th Annual Medical Device Global Labeling Strategies Hilton Minneapolis, Minneapolis Marcus Evans, http://www...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Entrepreneurs
Susan Flinn Cobian Title: Executive VP, Managing Director Company: HYC Health Education: BA, Kenyon College Family: Husband, Randy Robert Cobian Hobbies: Golf and paddle tennis Bucket List: To spend two weeks in Ireland and Scotland playing golf; to sing on the stage of the Grand Ole Opry; to com...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Clinical Experts
Lindy Jones Title: Senior VP, Site Management and Therapeutic Strategy, Chair of EMEA LA Management Board Company: Quintiles Education: MSc, Clinical Research, University of Wales Cardiff Family: Husband, Gareth; children Sara and Christian Hobbies: Boating, cooking, and wine sharing with friends...
By PharmaVoice Team • Aug. 1, 2016 -
PharmaVoice Team/PharmaVoice
Last Word
Patient-Centricity: More than a Catch Phrase John McCarthy, VP of Global Commercial Excellence at AstraZeneca, talks about why putting patients first should be a core focus of the biopharma industry. PV: How is AstraZeneca addressing the trend of patient-centricity? McCarthy: Patient-centricity c...
By John McCarthy • June 1, 2016 -
PharmaVoice Team/PharmaVoice
UpFront
Industry at Large AstraZeneca and Diabetes Hands Foundation Partner to Help Adults Walk Their Way to Better Health AstraZeneca and the Diabetes Hands Foundation have launched Everyday Steps, a new campaign designed to help the almost 28 million Americans with type 2 diabetes develop and maintain ...
By PharmaVoice Team • May 1, 2016 -
PharmaVoice Team/PharmaVoice
Diagnosing CNS Diseases
Neurological disorders comprise more than 600 conditions that affect the nervous system, impacting an estimated 50 million Americans every year. In the last few years, a tremendous push for new research of the brain has begun, in part, enabled by the National Institutes of Health BRAIN Initiative...
By Denise Myshko • May 1, 2016 -
PharmaVoice Team/PharmaVoice
India Stamps Its Mark on the Global Pharma Market
India is one of the great economic success stories; the country has enjoyed rapid growth and development over recent years. Today, it is the world’s fourth-largest economy and according to the IMF, the country is expected to realize 7.5% GDP in 2016-2017. With 1.2 billion people, India has the se...
By Kim Ribbink • May 1, 2016 -
PharmaVoice Team/PharmaVoice
Preparing for an Outcomes-based Sales Model
According to a recent report by Accenture, three factors — reimbursement models, changing buyer profiles, and digital capabilities — are changing the pharmaceutical and healthcare industries and directly impacting the traditional pharmaceutical sales rep model. However, these factors also represe...
By Robin Robinson • March 1, 2016 -
PharmaVoice Team/PharmaVoice
Gaining Value from the EHR Analytics
In January of this year, the Centers for Medicare & Medicaid Services (CMS) announced its plan to transition from the staged meaningful use program to a new program that would put patients and their outcomes at the center of how it pays for care and supports physicians. The intent is to conti...
By Robin Robinson • March 1, 2016 -
PharmaVoice Team/PharmaVoice
Caring for Those with Brain Disorders
Many of us will be caregivers at some point in our lives. Age, debilitating disease, and chronic health conditions mean many of us will take on the role of caring for relatives. An estimated 43.5 million adults in the United States have provided unpaid care to an adult or a child in the prior 12 ...
By Denise Myshko • March 1, 2016 -
PharmaVoice Team/PharmaVoice
Despite Turbulence, Russia's Pharma Market Holds Promise
The world’s largest nation, Russia remains an attractive market for most industries. Nevertheless, the country has struggled through a rough economic period, rocked by a drop in the value of the currency and turbulence in the oil market. Geopolitical pressures have raised challenges, including sa...
By Kim Ribbink • March 1, 2016 -
PharmaVoice Team/PharmaVoice
Last Word
Patient Advocacy in Rare Diseases Michelle Berg, VP of Patient Advocacy at Abeona Therapeutics, talks about the role biopharma companies can play in being a liaison between the scientific community and patients. PV: Why is patient advocacy important in rare diseases? Berg: The role for pharmaceut...
By Michelle Berg • Feb. 1, 2016
Previous
